Cianna Medical has secured an additional FDA 510(k) clearance for the SAVI SCOUT radar localisation system, enabling the reflector to be placed at the lumpectomy site up to 30 days before surgical removal.

SCOUT a medical device uses radar in human tissue for localising and directing the removal of non-palpable breast lesions.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Cianna Medical president and CEO Jill Anderson said: “Extending the timeframe between tumor localisation and surgical intervention has the potential to improve scheduling flexibility for patients, physicians and health systems, further supporting the use of radar as a desirable platform technology for tumour localisation.

"In cases where localisation was performed, targeted lesions and reflectors were removed with success and without any observed reflector migration."

“SCOUT is a novel technology, requiring no radiation or invasive wires, that has demonstrated the potential to drive value by reducing costs and improving patient outcomes.”

Data that was peer-reviewed and recently published in the July issue of Annals of Surgical Oncology indicated 100% surgical success, with significantly lower repeat surgery rates than those using wire localisation.

In cases where localisation was performed, targeted lesions and reflectors were removed with success and without any observed reflector migration.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In an another key study finding, researchers found that the SCOUT reflector could detect up to 5cm from the handpiece.

The FDA-cleared SCOUT system comes with a reflector that is placed at the tumour site up to 30 days before a lumpectomy or surgical biopsy.

During this procedure, surgeons can scan the breast using the SCOUT handpiece, which in turn emits infrared light and a micro-impulse radar signal that helps with detection of the location of the reflector.

Surgeons can exactly locate the reflector, along with the target tissue.

Due to this higher level of localisation precision, better surgical planning is possible to improve cosmetic results.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact